Perioperative prophylaxis of venous thromboembolism

R. Kumar, W. P. McKinney, G. Raj

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Venous thromboembolism is an important cause of morbidity and mortality in hospitalized patients, causing 100,000 to 200,000 deaths per year in the United States. Patients undergoing surgery are at the highest risk of venous thromboembolism. The magnitude of this risk in a patient depends on the surgical procedure performed and the presence of other risk factors that predispose to venous thromboembolism. The clinical diagnosis of both deep vein thrombosis and pulmonary embolism is notoriously inaccurate. Furthermore, two thirds of all fatal pulmonary emboli cause death within 30 minutes of the embolic episode, leaving little time for diagnostic work-up and effective treatment. Prophylactic treatment for prevention of venous thromboembolism is therefore important in these patients, and several effective mechanical and chemical methods for this purpose are available. The pathogenesis of deep vein thrombosis in the surgical patients, the predisposing risk factors, and the available prophylactic modalities are discussed in this article. Recommendations for the use of various approaches in different risk categories are provided.

Original languageEnglish (US)
Pages (from-to)336-344
Number of pages9
JournalAmerican Journal of the Medical Sciences
Volume306
Issue number5
StatePublished - 1993

Fingerprint

Venous Thromboembolism
Venous Thrombosis
Embolism
Pulmonary Embolism
Causality
Cause of Death
Morbidity
Lung
Mortality
Therapeutics

Keywords

  • Anticoagulants
  • Pulmonary embolism
  • Thrombophlebitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Perioperative prophylaxis of venous thromboembolism. / Kumar, R.; McKinney, W. P.; Raj, G.

In: American Journal of the Medical Sciences, Vol. 306, No. 5, 1993, p. 336-344.

Research output: Contribution to journalArticle

Kumar, R. ; McKinney, W. P. ; Raj, G. / Perioperative prophylaxis of venous thromboembolism. In: American Journal of the Medical Sciences. 1993 ; Vol. 306, No. 5. pp. 336-344.
@article{8f1cf56fb4d94b02b791869c0de804f5,
title = "Perioperative prophylaxis of venous thromboembolism",
abstract = "Venous thromboembolism is an important cause of morbidity and mortality in hospitalized patients, causing 100,000 to 200,000 deaths per year in the United States. Patients undergoing surgery are at the highest risk of venous thromboembolism. The magnitude of this risk in a patient depends on the surgical procedure performed and the presence of other risk factors that predispose to venous thromboembolism. The clinical diagnosis of both deep vein thrombosis and pulmonary embolism is notoriously inaccurate. Furthermore, two thirds of all fatal pulmonary emboli cause death within 30 minutes of the embolic episode, leaving little time for diagnostic work-up and effective treatment. Prophylactic treatment for prevention of venous thromboembolism is therefore important in these patients, and several effective mechanical and chemical methods for this purpose are available. The pathogenesis of deep vein thrombosis in the surgical patients, the predisposing risk factors, and the available prophylactic modalities are discussed in this article. Recommendations for the use of various approaches in different risk categories are provided.",
keywords = "Anticoagulants, Pulmonary embolism, Thrombophlebitis",
author = "R. Kumar and McKinney, {W. P.} and G. Raj",
year = "1993",
language = "English (US)",
volume = "306",
pages = "336--344",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Perioperative prophylaxis of venous thromboembolism

AU - Kumar, R.

AU - McKinney, W. P.

AU - Raj, G.

PY - 1993

Y1 - 1993

N2 - Venous thromboembolism is an important cause of morbidity and mortality in hospitalized patients, causing 100,000 to 200,000 deaths per year in the United States. Patients undergoing surgery are at the highest risk of venous thromboembolism. The magnitude of this risk in a patient depends on the surgical procedure performed and the presence of other risk factors that predispose to venous thromboembolism. The clinical diagnosis of both deep vein thrombosis and pulmonary embolism is notoriously inaccurate. Furthermore, two thirds of all fatal pulmonary emboli cause death within 30 minutes of the embolic episode, leaving little time for diagnostic work-up and effective treatment. Prophylactic treatment for prevention of venous thromboembolism is therefore important in these patients, and several effective mechanical and chemical methods for this purpose are available. The pathogenesis of deep vein thrombosis in the surgical patients, the predisposing risk factors, and the available prophylactic modalities are discussed in this article. Recommendations for the use of various approaches in different risk categories are provided.

AB - Venous thromboembolism is an important cause of morbidity and mortality in hospitalized patients, causing 100,000 to 200,000 deaths per year in the United States. Patients undergoing surgery are at the highest risk of venous thromboembolism. The magnitude of this risk in a patient depends on the surgical procedure performed and the presence of other risk factors that predispose to venous thromboembolism. The clinical diagnosis of both deep vein thrombosis and pulmonary embolism is notoriously inaccurate. Furthermore, two thirds of all fatal pulmonary emboli cause death within 30 minutes of the embolic episode, leaving little time for diagnostic work-up and effective treatment. Prophylactic treatment for prevention of venous thromboembolism is therefore important in these patients, and several effective mechanical and chemical methods for this purpose are available. The pathogenesis of deep vein thrombosis in the surgical patients, the predisposing risk factors, and the available prophylactic modalities are discussed in this article. Recommendations for the use of various approaches in different risk categories are provided.

KW - Anticoagulants

KW - Pulmonary embolism

KW - Thrombophlebitis

UR - http://www.scopus.com/inward/record.url?scp=0027431732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027431732&partnerID=8YFLogxK

M3 - Article

C2 - 8238091

AN - SCOPUS:0027431732

VL - 306

SP - 336

EP - 344

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 5

ER -